WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of October 31, 2025
Asset Allocation
Equity: 90.89%Others: 9.11%
Market Cap
Large Cap: 18.88%Small Cap: 46.07%Mid Cap: 23.96%Equity: 1.98%
Number of stocks
60
Top 10 Holdings
99.18% of portfolio
Market Cap of Equity
Large Cap
18.8760%
Small Cap
46.0656%
Mid Cap
23.9602%
Equity
1.9843%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd15.63%
Divi's Laboratories Ltd13.73%
J.B. Chemicals & Pharmaceuticals Ltd12.97%
Fortis Healthcare Ltd12.64%
Laurus Labs Ltd9.36%
Cipla Ltd8.39%
Neuland Laboratories Ltd7.65%
Lupin Ltd7.46%
Sai Life Sciences Ltd5.89%
Krishna Institute of Medical Sciences Ltd5.46%
Sector Allocation of Equity
Healthcare87.71%
Basic Materials3.18%
Financial Services0.00%
SIP Amount
Monthly SIP Date
WhiteOak Capital Pharma and Healthcare Fund-Reg (G)


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.